Lv512
1330 积分 2025-04-02 加入
Current Insights into CAR T-Cell-Based Therapies for Myelodysplastic Syndrome
21小时前
已完结
Cellular and immunotherapies for myelodysplastic syndromes
21小时前
已完结
CAR-T cell therapy in AML: recent progress and future perspectives
21小时前
已完结
CAR-T cell therapy for cancer: current challenges and future directions
3天前
已完结
Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report
3天前
已完结
Advances and challenges in the treatment of myelodysplastic syndromes
4天前
已完结
Outcome of Patients With Acute Myeloid Leukemias or Myelodysplastic Syndromes After Relapsing From Allogeneic Stem Cell Transplantation: The GITMO AML/MDS‐Relapse Registry Study
4天前
已完结
How I reduce and treat posttransplant relapse of MDS
4天前
已完结
Lenalidomide as a second‐line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome
4天前
已完结
皖公网安备34019202002308
